https://stock.noler.com/us/stock/nexien-biopharma-inc https://stock.noler.com/us/stock/nexien-biopharma-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/nexien-biopharma-inc/accounts-payable-related-parties-current https://stock.noler.com/us/stock/nexien-biopharma-inc/accounts-payable-trade-current https://stock.noler.com/us/stock/nexien-biopharma-inc/accrued-liabilities-current https://stock.noler.com/us/stock/nexien-biopharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/nexien-biopharma-inc/advertising-expense https://stock.noler.com/us/stock/nexien-biopharma-inc/amortization-of-acquisition-costs https://stock.noler.com/us/stock/nexien-biopharma-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/nexien-biopharma-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/nexien-biopharma-inc/basic-shares https://stock.noler.com/us/stock/nexien-biopharma-inc/cash https://stock.noler.com/us/stock/nexien-biopharma-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/nexien-biopharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/nexien-biopharma-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/nexien-biopharma-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/nexien-biopharma-inc/cash-change https://stock.noler.com/us/stock/nexien-biopharma-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/nexien-biopharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/nexien-biopharma-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/nexien-biopharma-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/nexien-biopharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nexien-biopharma-inc/common-stock-shares-subscriptions https://stock.noler.com/us/stock/nexien-biopharma-inc/common-stock-value https://stock.noler.com/us/stock/nexien-biopharma-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/nexien-biopharma-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/nexien-biopharma-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/nexien-biopharma-inc/costs-and-expenses https://stock.noler.com/us/stock/nexien-biopharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/nexien-biopharma-inc/current-assets https://stock.noler.com/us/stock/nexien-biopharma-inc/current-liabilities https://stock.noler.com/us/stock/nexien-biopharma-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/nexien-biopharma-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/nexien-biopharma-inc/debt-face-amount https://stock.noler.com/us/stock/nexien-biopharma-inc/debt-increase-accrued-interest https://stock.noler.com/us/stock/nexien-biopharma-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/nexien-biopharma-inc/debt-unamortized-discount https://stock.noler.com/us/stock/nexien-biopharma-inc/debt-unamortized-discount-current https://stock.noler.com/us/stock/nexien-biopharma-inc/debt-unamortized-discount-noncurrent https://stock.noler.com/us/stock/nexien-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/nexien-biopharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nexien-biopharma-inc/deposit-liabilities-accrued-interest https://stock.noler.com/us/stock/nexien-biopharma-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/nexien-biopharma-inc/diluted-shares https://stock.noler.com/us/stock/nexien-biopharma-inc/due-from-other-related-parties-current https://stock.noler.com/us/stock/nexien-biopharma-inc/due-from-related-parties-current https://stock.noler.com/us/stock/nexien-biopharma-inc/due-from-related-parties-noncurrent https://stock.noler.com/us/stock/nexien-biopharma-inc/due-to-officers-or-stockholders-current https://stock.noler.com/us/stock/nexien-biopharma-inc/due-to-related-parties-current https://stock.noler.com/us/stock/nexien-biopharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/nexien-biopharma-inc/effective-tax-rate https://stock.noler.com/us/stock/nexien-biopharma-inc/eps https://stock.noler.com/us/stock/nexien-biopharma-inc/eps-basic https://stock.noler.com/us/stock/nexien-biopharma-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/nexien-biopharma-inc/fair-value-net-asset-liability https://stock.noler.com/us/stock/nexien-biopharma-inc/financing-cash-flow https://stock.noler.com/us/stock/nexien-biopharma-inc/form-d-other https://stock.noler.com/us/stock/nexien-biopharma-inc/form-d-stocks https://stock.noler.com/us/stock/nexien-biopharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/nexien-biopharma-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/nexien-biopharma-inc/increase-decrease-due-from-officers-and-stockholders https://stock.noler.com/us/stock/nexien-biopharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/nexien-biopharma-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/nexien-biopharma-inc/increase-decrease-in-accounts-payable-related-parties https://stock.noler.com/us/stock/nexien-biopharma-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/nexien-biopharma-inc/increase-decrease-in-accrued-interest-receivable-net https://stock.noler.com/us/stock/nexien-biopharma-inc/increase-decrease-in-due-from-related-parties https://stock.noler.com/us/stock/nexien-biopharma-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/nexien-biopharma-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/nexien-biopharma-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/nexien-biopharma-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/nexien-biopharma-inc/insider-transactions-warrants https://stock.noler.com/us/stock/nexien-biopharma-inc/interest-expense https://stock.noler.com/us/stock/nexien-biopharma-inc/interest-expense-other https://stock.noler.com/us/stock/nexien-biopharma-inc/interest-expense-related-party https://stock.noler.com/us/stock/nexien-biopharma-inc/interest-payable-current https://stock.noler.com/us/stock/nexien-biopharma-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/nexien-biopharma-inc/investing-cash-flow https://stock.noler.com/us/stock/nexien-biopharma-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/nexien-biopharma-inc/management-fee-expense https://stock.noler.com/us/stock/nexien-biopharma-inc/net-change-in-cash https://stock.noler.com/us/stock/nexien-biopharma-inc/net-income https://stock.noler.com/us/stock/nexien-biopharma-inc/operating-cash-flow https://stock.noler.com/us/stock/nexien-biopharma-inc/operating-expenses https://stock.noler.com/us/stock/nexien-biopharma-inc/operating-income https://stock.noler.com/us/stock/nexien-biopharma-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/nexien-biopharma-inc/other-current-assets https://stock.noler.com/us/stock/nexien-biopharma-inc/other-current-liabilities https://stock.noler.com/us/stock/nexien-biopharma-inc/other-expenses https://stock.noler.com/us/stock/nexien-biopharma-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/nexien-biopharma-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/nexien-biopharma-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/nexien-biopharma-inc/paid-in-capital-other https://stock.noler.com/us/stock/nexien-biopharma-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/nexien-biopharma-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/nexien-biopharma-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/nexien-biopharma-inc/payments-for-deposits https://stock.noler.com/us/stock/nexien-biopharma-inc/payments-for-repurchase-of-initial-public-offering https://stock.noler.com/us/stock/nexien-biopharma-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/nexien-biopharma-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/nexien-biopharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/nexien-biopharma-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nexien-biopharma-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/nexien-biopharma-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/nexien-biopharma-inc/prepaid-expense-current https://stock.noler.com/us/stock/nexien-biopharma-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/nexien-biopharma-inc/proceeds-from-divestiture-of-businesses-and-interests-in-affiliates https://stock.noler.com/us/stock/nexien-biopharma-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/nexien-biopharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/nexien-biopharma-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/nexien-biopharma-inc/professional-fees https://stock.noler.com/us/stock/nexien-biopharma-inc/public-float https://stock.noler.com/us/stock/nexien-biopharma-inc/related-party-transaction-due-from-to-related-party https://stock.noler.com/us/stock/nexien-biopharma-inc/related-party-transaction-due-from-to-related-party-current https://stock.noler.com/us/stock/nexien-biopharma-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/nexien-biopharma-inc/research-and-development https://stock.noler.com/us/stock/nexien-biopharma-inc/retained-earnings https://stock.noler.com/us/stock/nexien-biopharma-inc/revenue https://stock.noler.com/us/stock/nexien-biopharma-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/nexien-biopharma-inc/share-price https://stock.noler.com/us/stock/nexien-biopharma-inc/share-repurchases https://stock.noler.com/us/stock/nexien-biopharma-inc/shareholders-equity https://stock.noler.com/us/stock/nexien-biopharma-inc/shares-authorized https://stock.noler.com/us/stock/nexien-biopharma-inc/shares-issued https://stock.noler.com/us/stock/nexien-biopharma-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-non-option-equity-instruments-exercised https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-non-option-equity-instruments-expirations https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-non-option-equity-instruments-forfeitures-and-expirations https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-award-rsu-aggregate-intrinsic-value-vested https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-based-compensation https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-issued-shares-issued-value-share-based-compensation-forfeited https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/nexien-biopharma-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/nexien-biopharma-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/nexien-biopharma-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/nexien-biopharma-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nexien-biopharma-inc/total-assets https://stock.noler.com/us/stock/nexien-biopharma-inc/total-liabilities https://stock.noler.com/us/stock/nexien-biopharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/nexien-biopharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted